Education
About Us
Working with TipRanks
Follow Us
Staar Surgical (STAA)
NASDAQ:STAA
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.56Last Year’s EPS
0.39Same Quarter Last Year
Based on 9 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: -1.13%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strategic management changes and positive sales growth outside China, along with cost optimization efforts and increased manufacturing capacity. However, significant revenue decline in China, lower profitability, decreased gross margin, and tariff challenges presented notable challenges.Company Guidance
During the STAAR Surgical first quarter 2025 earnings call, CEO Steve Farrell highlighted several key metrics and strategic initiatives aimed at addressing short-term tactical challenges and driving long-term growth. The company reported total net sales of $42.6 million for the quarter, a decline from $77.4 million in the previous year, largely due to minimal purchases by China distributors, who were consuming existing inventory. Despite this, sales outside China grew by 9% year-over-year. STAAR's efforts to mitigate the impact of China's tariffs included consignment agreements and strategic inventory placement, with expectations for normalized sales to resume by Q3. The company also undertook cost-cutting measures aimed at achieving a $225 million SG&A run rate by year-end, while targeting a 70% gross margin in the second half of 2025. The management team is optimistic about the future, driven by their proprietary technology, growing market opportunities, and strategic expansions, particularly in manufacturing capabilities in Switzerland.Positive Global Sales Growth Outside China
Net sales excluding China were $42.2 million for the first quarter of 2025, representing 9% sales growth over the year ago quarter.
Strategic Management Changes
Streamlined management structure, including the promotion of Warren Faust to President and the appointment of Deborah Andrews as Interim CFO.
Cost Optimization Efforts
Identified actions to meaningfully reduce costs, targeting an SG&A run rate of approximately $225 million by the end of 2025.
Continued ICL Demand and Growth in China
Despite a dramatic reduction in reported revenue, in-market ICL procedures in China are believed to be similar to or better than the first quarter of 2024.
Expansion of Manufacturing Capacity
Increased manufacturing capacity in Switzerland with a potential output of 300,000 lenses a year by the end of 2026, with longer-term potential for over 800,000 lenses annually.
---
STAA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
STAA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2025 | $19.44 | $19.53 | +0.46% |
Feb 11, 2025 | $21.88 | $16.48 | -24.68% |
Oct 30, 2024 | $29.49 | $28.99 | -1.70% |
Aug 07, 2024 | $36.35 | $40.36 | +11.03% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Staar Surgical (STAA) report earnings?
Staar Surgical (STAA) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Staar Surgical (STAA) earnings time?
Staar Surgical (STAA) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is STAA EPS forecast?
STAA EPS forecast for the fiscal quarter 2025 (Q2) is -0.56.
---